News

Teva has announced the FDA approval and launch of Oxaliplatin Injection. Teva’s 505(b)(2) New Drug Application provides for the use of Oxaliplatin Injection, 50mg/10ml and 100mg/20ml, for adjuvant

Alnylam and Regulus Therapeutics (Regulus) have reported that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for the Manoharan patent (application number 11/200703),

Additionally, Olsen, who is the company’s current chief operating officer, will continue to serve in that capacity for both divisions while the board of directors engages in a

The Quantum Group is going to deploy the third version of PWeR (Personal Wellness electronic Record), PWeR 3.0, within the next 30 days. The company claims that the

Labcyte has selected Tekon Biotech as its distributor in China, including Hong Kong and Taiwan. Stephen Bates, SVP of sales, marketing and service of Labcyte, said: “As we

LRGHealthcare has signed an agreement with IntraNexus to purchase the latter’s SAPPHIRE clinical software suite, including clinical management, advanced documentation, pharmacy, lab, radiology, and scheduling and document management.

Carefx has announced the availability of eReferral, a portal-based referral management solution that enables hospitals, IDNs and HIEs to establish a streamlined, patient-centric and accountable process for tracking

Identity Force provides a complete identity theft and fraud prevention risk analysis, full policy and procedure creation, and multi-media training and support designed to bring an organization into

Ikaria has acquired the exclusive worldwide license to Fibrex Medical’s portfolio of investigational compounds, for a range of critical care conditions. The investigational compounds – FX06, FX201, and